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The Wnt pathway controls cell fates, tissue ho-
meostasis, and cancer. Its activation entails the
association of b-catenin with nuclear TCF/LEF
proteins and results in transcriptional activation
of target genes. The mechanism by which nu-
clear b-catenin controls transcription is largely
unknown. Here we genetically identify a novel
Wnt/Wg pathway component that mediates
the transcriptional outputs of b-catenin/Arma-
dillo. We show that Drosophila Hyrax and its
human ortholog, Parafibromin, components of
the Polymerase-Associated Factor 1 (PAF1) com-
plex, are required for nuclear transduction of
theWnt/Wg signal and bind directly to the C-ter-
minal region of b-catenin/Armadillo. More-
over, we find that the transactivation potential
of Parafibromin/Hyrax depends on the recruit-
ment of Pygopus to b-catenin/Armadillo. Our
results assign to the tumor suppressor Parafi-
bromin an unexpected role in Wnt signaling
and provide a molecular mechanism for Wnt
target gene control, in which the nuclear Wnt
signaling complex directly engages the PAF1
complex, thereby controlling transcriptional ini-
tiation and elongation by RNA Polymerase II.
INTRODUCTION
The development and homeostasis of multicellular organ-
isms largely depends on cell-to-cell communication for the
establishment and coordination of cell fates and the con-
trol of organ growth. Certain signaling molecules form con-
centration or activity gradients to provide cells in a tissue
with positional information. Members of the Hedgehog
and Wnt families of secreted signaling proteins, for exam-
ple, induce subsets of target genes at defined distances
from their source by activating conserved transductioncascades. Aberrant activation of these pathways can
lead to various types of human cancer (Taipale and
Beachy, 2001; reviewed by Gregorieff and Clevers, 2005).
The canonical Wnt/Wingless (Wg) pathway controls
transcription of target genes via its central component
b-catenin (or itsDrosophila homolog Armadillo, Arm), which
serves as an interaction hub for a complex array of mem-
brane-associated, cytosolic, and nuclear proteins (re-
viewed by Daniels et al., 2001). At the cell membrane,
b-catenin associates with a-catenin and E-cadherin in
adherens junctions to provide a cell adhesion function.
The remaining cytoplasmic b-catenin protein is constitu-
tively marked for proteasomal degradation by Glycogen
Synthase Kinase 3b (GSK-3b)-mediated phosphorylation
(reviewed by Peifer and Polakis, 2000). GSK-3b is part of
a degradation complex also comprising Axin and APC,
the product of the Adenomatous Polyposis Coli tumor
suppressor gene. Upon binding of an extracellular Wnt
ligand to members of the Frizzled (Fz) and LRP/Arrow
receptors, Dishevelled (Dsh) is activated and assumed to
disrupt the b-catenin degradation complex. As a result,
the levels of free cytoplasmic b-catenin rise, and b-catenin
enters the nucleus and interacts with TCF/LEF DNA bind-
ing proteins to initiate transcription of Wnt-responsive
genes (reviewed by Nelson and Nusse, 2004).
Key to understanding the evolution and function of
b-catenin signaling and the consequences of aberrant
b-catenin activity in cancer is the question of how a cell
adhesion component, relocated to the nucleus, can pro-
mote and sustain transcription of genes. Although a num-
ber of interacting proteins have been identified, it is still
poorly understood how they endow b-catenin with the
ability to control the transcription of its targets. For exam-
ple, the recent discovery and characterization of BCL9/
Legless (Lgs) and Pygopus (Pygo) indicated that Lgs links
Pygo to b-catenin to form a core complex with TCF/LEF
(Kramps et al., 2002; Hoffmans et al., 2005), but how this
complex uses Pygo to control the transcription of Wnt
targets remains a mystery.
b-catenin consists of a central region containing 12
stacked Arm repeats flanked by structurally less well de-
fined N- and C-terminal domains (NTD and CTD). TheCell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc. 327
Arm repeat region mediates the binding to cadherins, Axin/
APC and TCF/LEF, allowingb-catenin to associate with ad-
herens junctions, its destruction complex, or indirectly with
DNA, respectively. Various lines of experimental evidence
suggest that the two main outputs of b-catenin relating to
its transcriptional activity emanate from its most N-termi-
nally located Arm repeats as well as from its C-terminal re-
gion (Orsulic and Peifer, 1996; Hecht et al., 2000; Kramps
et al., 2002). The N-terminal activity can be attributed to
the recruitment of Lgs and Pygo (Hoffmans et al., 2005;
Sta¨deli and Basler, 2005). In contrast, the transactivation
activity imparted by the C-terminal part appears to be
more complex since at least for Arm it has been found to
stem from several subregions, of which the region closest
to Arm repeat 12 plays the most important role for pathway
output in vivo (Orsulic et al., 1996;Cox et al., 1999). Proteins
implicated inbinding these C-terminal regions ofb-catenin/
Arm include the histone acetyltransferases CBP and p300
and the ATP-dependent histone remodeling factor Brg1/
Brahma (Brm) (Hecht et al., 2000; Takemaru and Moon,
2000; Barker et al., 2001), representing components of
a general toolbox for chromatin remodeling (reviewed by
Narlikar et al., 2002). In addition to reorganized chromatin,
transcriptional activation also depends on the recruitment
and preparation of RNA Polymerase II (RNAPII) for the initi-
ation and elongation of mRNA synthesis. However, for
many signaling cascades, including the Wnt pathway,
the mechanisms by which these later steps in transcrip-
tional control are mediated remain poorly understood.
In this report, we describe the genetic identification and
molecular characterization of Hyrax (Hyx), a novel com-
ponent of the nuclear Wnt/Wg signaling pathway in Dro-
sophila. Hyx is homologous to yeast Cdc73p, a component
of the Polymerase-Associated Factor 1 (PAF1) complex,
and is the Drosophila ortholog of human Parafibromin,
the protein product of the Hyperparathyroidism-Jaw Tu-
mor syndrome (HTP-JT) tumor suppressor gene HRPT2.
Overexpression of Hyx is able to counteract compromised
Lgs/Pygo activity. Conversely, reduction of Hyx function in
vivo, as well as the knock-down of hyx or HRPT2 expres-
sion in cultured cells, abrogates Arm/b-catenin-mediated
transduction of Wg and Wnt signals, respectively. These
results reveal a novel and unanticipated role for Parafibro-
min as an important component of nuclear Wnt signaling.
Moreover, we show that an N-terminal region of Parafibro-
min/Hyx directly interacts with the C-terminal region of b-
catenin/Arm. Our results suggest a mechanistic model for
Wnt/Wg target gene control in which the Pygo-mediated
and the C-terminal outputs of b-catenin/Arm converge in
the recruitment of the PAF1 complex, thereby activating
transcriptional initiation and elongation by RNAPII.
RESULTS
Identification of hyx in a Genetic Screen
for Wg Signaling Components
In a previous effort to isolate rate-limiting components of
the Wnt/Wg signal transduction pathway, we carried out328 Cell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc.a screen for dosage-sensitive genes required for the man-
ifestation of a gain-of-Wg-signaling phenotype in the Dro-
sophila eye (Brunner et al., 1997; Kramps et al., 2002). This
screen uncovered mutations in the pangolin (pan), arm,
lgs, and pygo genes, encoding the Drosophila homologs
of TCF/LEF, b-catenin, BCL9, and Pygo, respectively,
which together appear to form a tetrapartite DNA bound
complex to control Wnt/Wg target genes (Belenkaya
et al., 2002; Kramps et al., 2002; Parker et al., 2002;
Thompson et al., 2002). In an attempt to identify factors
mediating the transcriptional output of this complex, we
designed a complementary assay for genes that upon
overexpression ameliorate a partial loss-of-Wg-signaling
phenotype. A mutant form of Lgs (Lgs17E), which has
weakened Arm binding capacity (Kramps et al., 2002),
was overexpressed in the wing pouch primordium, caus-
ing a notched wing margin phenotype by interfering in
a dominant-negative manner with Arm-Lgs activity (Fig-
ures 1A–1C). We isolated two allelic EP-element inser-
tions, P9 and P10, which effectively reverted the Lgs17E
phenotype (Figure 1D and data not shown) when driven
by Gal4 during larval development. However, ectopic
gene expression driven by the P9 and P10 elements had
no effect (1) on the viability or morphology of wild-type an-
imals, (2) on phenotypes sensitized for the Dpp, Insulin,
EGFR, and TNF/Eiger signaling pathways (see Experi-
mental Procedures), nor (3) on the activity of the wing
pouch enhancer used to drive Lgs17E expression (Figures
1H–1J).
The P9 and P10 elements inserted at cytological posi-
tion 85C3 between two genes transcribed in opposite di-
rections (Figure 1G): neuralized (neur), which encodes an
E3 ubiquitin ligase involved in Notch signaling (Yeh et al.,
2001), and CG11990, a novel gene that we refer to as hy-
rax (hyx). Direct UAS-hyx transgenes based on a full-
length cDNA faithfully reproduced the reversion activity
of the EP-elements (Figure 1E). Taken together, our results
indicate that hyx encodes a normally non-rate-limiting
product which upon overexpression is able to specifically
overcome the dominant-negative action of Lgs17E, raising
the possibility that it functions as a novel, positive compo-
nent in the Wg pathway.
hyx Is an Essential Gene Required
for Wg Signal Transduction
To gain more insight into hyx function, we sought to gen-
erate mutant hyx alleles. We used the fully penetrant rever-
sion of the Lgs17E phenotype by P9 activity as the basis for
an EMS mutagenesis screen. Two revertant P9 chromo-
somes were recovered which failed to suppress the
Lgs17E phenotype (Figure 1F and data not shown) and
also failed to complement each other. Sequence analysis
of the hyx locus of both chromosomes revealed premature
stop codons in the hyx open reading frame (at R505 and
Q461, respectively) (Figure 1G). We refer to these mutant
hyx alleles as hyx1 and hyx2. We subsequently identified
a third, strongly hypomorphic hyx allele, caused by the
Figure 1. Overexpression of hyx Can Reverse the Dominant-Negative Effect of lgs17E
(A–F) Expression of UAS-lgs17E driven by spalt major enhancer-Gal4 (salE>lgs17E) causes wing notches (compare [A] and [B]). This phenotype is un-
affected by cooverexpression of UAS-GFPNLS (C) but is completely reverted by cooverexpression of hyx either via P-element P9 (D) or P10 (data not
shown) or by a UAS-hyx transgene (E). A mutant form of hyx recovered from EMS reversion mutagenesis is unable to rescue the salE>lgs17E pheno-
type (F).
(G) Schematic representation of the hyx locus (coding sequences in yellow and untranslated regions (UTR) in blue). hyx1 and hyx2 indicate the position
of stop codons in the EMS alleles.
(H–J) Clonal overexpression of hyx does not influence the expression of the salE element as reported by lacZ expression (blue). The pouch region of
a wing imaginal disc is shown. GFP (green) indicates clonal activity of an Act5C>CD2>Gal4 construct (in which the CD2 cassette was excised) in
a background containing UAS-GFPNLS, UAS-hyx, salE-lacZ, and hsp70-flp.
(K and L) The early lethality of the hyxEY6898 allele can be partially rescued to pharate adults by the presence of the ubiquitous Act5C-Gal4 driver (res-
cuing hyx transcription from the exogenous promoter of the EP-element). The legs of such animals exhibit severe defects with shortened and twisted
segments.EP-element insertion EY6898 into the hyx 50 UTR
(hyxEY6898) (Figure 1G).
Disruption of hyx function causes lethality during late
embryogenesis (hyx1 and hyx2) or shortly after hatching
(hyxEY6898) without obvious phenotypes. The early larval
lethality of the hyxEY6898 allele could be substantially res-
cued to pharate adult stages by the presence of a ubiqui-
tous Gal4 driver (rescuing hyx transcript formation from
the exogenous promoter of the EP-element). Such ani-
mals exhibit severe leg defects with shortened and twisted
segments (Figures 1K and 1L), reminiscent of phenotypes
caused by hypomorphic pan and pygo alleles (Brunner
et al., 1997; Parker et al., 2002; Thompson et al., 2002)
as well as of the stubby legged habitus of the rock hyrax
(Procavia capensis) (Hoeck, 1990).
We next generated clones of cells mutant for hyx by
FLP-mediated mitotic recombination. Homozygous mu-tant clones in the adult female germ line did not develop
into fertile oocytes. Hence maternal hyx products could
not be removed to assess their role in patterning the em-
bryonic epidermis. Similarly, somatic cell clones of the
strong alleles hyx1 and hyx2 were rapidly eliminated from
imaginal tissues. However, hyxEY6898 mutant cell clones
induced 48 hr to 72 hr after egg laying grew readily in all
imaginal discs although more slowly than their wild-type
twinspots (data not shown). We thus continued our assays
using hxyEY6898 with the potential caveat that it might un-
cover only particularly sensitive aspects of hyx function.
hxyEY6898 clones in the wing imaginal disc showed a se-
vere reduction or loss of expression of Distal-less (Dll),
a target of the Wg pathway (Zecca et al., 1996; Neumann
and Cohen, 1997) (Figures 2A–2C). Failure to upregulate
Dll expression could in principle be attributed to either
a specific defect in Wg signal transduction or to a generalCell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc. 329
cellular defect. However, expression of the Notch target
gene cut (ct), the selector gene engrailed (en), the Hh tar-
get genes decapentaplegic (dpp) and patched (ptc), and
the Dpp target optomotor-blind (omb) was not impaired
in hyxEY6898 mutant clones (Figures 2D–2O and data not
shown), arguing against the latter explanation and sug-
gesting instead that the output of the Wg pathway is par-
ticularly susceptible to a reduction of hyx activity.
Mutant clones of hyx2 and hyxEY6898 could be recovered
in adult tissues when given a growth advantage by the
Minute technique and were associated with a variety of
phenotypes. Commonly observed abnormalities include
notches at the wing blade margin and leg defects similar
to those of hyx pharate adults (see above, Figures 2P
and 2Q). Mutant clones in the notum region frequently
caused the absence of thoracic dorsocentral macrochae-
tae (data not shown), a phenotype previously described
for impaired Wg signaling (Phillips and Whittle, 1993).
We also noted patterning abnormalities that have no obvi-
ous relationship to Wg signaling, such as formation of
ectopic vein material (Figure 2P) and deformed eye mor-
phology (data not shown). Collectively, therefore, we con-
clude that hyx is an essential gene and that it is required
autonomously in Wg receiving cells for the transduction
of the Wg signal. But, unlike dedicated Wg signaling com-
ponents, such as Lgs and Pygo, Hyx also plays a role in
other developmental processes.
Hyx Functions Downstream of Axin and APC2
To validate and extend our examinations of the role of Hyx
in the Wg pathway, we used a Drosophila S2 cell signaling
assay based on a stably integrated Luciferase reporter
construct containing multiple TCF/LEF binding sites
(Schweizer and Varmus, 2003). The pathway was acti-
vated by Wg secreted from cocultured cells (van Leeuwen
et al., 1994), resulting in potent induction of Luciferase ex-
pression (Figure 3A). Targeting transcripts of the negative
regulators Axin and APC2 by RNAi also increased the Lu-
ciferase readout, even in the absence of the Wg ligand.
Conversely, RNAi against sequences encoding the
positively acting components (dsh, arm, lgs, and pygo)
strongly reduced the transcriptional response to Wg
(Figure 3A and data not shown). Two different dsRNAs
for hyx were prepared; both caused a severe reduction
of Wg pathway activity (Figure 3A). Importantly, indepen-
dent Luciferase reporters systems designed to monitor
the response to other signals, e.g., Dpp or heavy metal
ions, were not significantly affected by hyx RNAi (Fig-
ure 3B). These results confirm our conclusion that hyx en-
codes a product required for Wg signaling output and
provide an experimental basis for analyzing the epistatic
relationship between Hyx and known components of the
Wg pathway.
We next employed combinatorial RNAi in our S2-cell re-
porter system. The transcriptional induction resulting from
RNAi against Axin (data not shown) or APC2 was signifi-
cantly reduced when dsRNA against lgs was included.
An even stronger reduction was obtained by administering330 Cell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc.Figure 2. hyxEY6898 Clones Show a Cell-Autonomous De-
crease in Distal-less Expression and Other Developmental
Defects but Not a General Impairment of Transcription
(A–O) Regions of wing primordia in which somatic hyxEY6898 clones are
marked by the absence of GFP (green). Expression of the Wg target
gene Dll is severely affected by hyx impairment (arrowheads), as re-
vealed by anti-Dll staining (A–C). This effect is not due to a uniform im-
pact on transcriptional outputs, as the Notch target cut (D–F), the Hh
target dpp (G–I), the Dpp target omb (J–L), and the selector gene en
(M–O) are still normally expressed in hyxEY6898 clones, as indicated
by the corresponding lacZ enhancer trap reporters.
(P) hyx Minute+ clones in a Minute– background develop wing notch
phenotypes typical for loss of Wg signaling (arrowheads) as well as
non-Wg-related defects such as extra vein material (asterisks).
(Q) Example of deformed leg segments from hyx clones in the same
background as in (P).
Figure 3. RNAi against hyx Reveals a Requirement in Wg Signal Transduction Downstream of APC2 and Axin
(A–C) Relative Luciferase activity is the ratio between Firefly and constitutively expressed Renilla luciferase levels. Each experiment was performed in
triplicate, and the error bars represent standard deviations.
(A) RNAi against arm, lgs, and hyx (depicted are two independent dsRNA probes, hyx and hyxb) decreases Wg signaling. The pathway is induced
by coculture of Wg producing cells (+S2 hs-wg); control is coculture of wild-type S2 cells (+S2). RNAi against Axin and APC2 potently activates
the pathway.
(B) RNAi against hyx has no effect on two independent Luciferase reporter systems where Firefly luciferase was driven by a brinker (brk) silencer el-
ement or a Metallothionein-inducible promoter (pMT).
(C) RNAi against hyx and lgs, but not GFP, significantly reduced the activation of the Wg reporter (stimulated by knocking down APC2).
(D and E) Expression of the Wg targets CG5895, dFz3, and nkd (D), but not of independent control genes (E), requires hyx. S2 cells were treated with
RNAi against Axin (to induce Wg targets) or GFP (control) in combination with dsRNA targeting GFP, lgs, or hyx. Genes of interest were analyzed by
quantitative RT-PCR. Expression levels were normalized to the GFP/GFP control.dsRNA against hyx (Figure 3C). We interpret these obser-
vations as an indication that Hyx, like Lgs, acts down-
stream of the Arm degradation complex in Wg transducing
cells.
In order to extend these findings to endogenous Wg tar-
get genes, we used quantitative RT-PCR (qRT-PCR) to
analyze the transcriptional behavior of D-frizzled 3 (Dfz3),naked cuticle (nkd), and CG5895, three genes presumed
to be direct targets of the Arm/Pan complex (Sivasankaran
et al., 2000; Zeng et al., 2000) (D. Soldini, C.M., and K.B.,
unpublished data). These genes were readily induced in
S2 cells upon RNAi-mediated knock-down of Axin (Fig-
ure 3D); the expression of all three genes, however, was
reverted to normal levels upon coadministration of RNAiCell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc. 331
Figure 4. Hyx Is a Highly Conserved Cdc73p-Related Protein with Homology to the Human Tumor Suppressor Parafibromin
(A) Dendrogram depicting the evolutionary relationship of potential Hyx homologs from various eukaryotic organisms. From yeast to humans, Hyx
homologs are encoded by single-copy genes. An exception are theDrosophilids (yet not insects in general), whose genomes contain a weakly related
gene (CG6220 in D. melanogaster) that appears to be expressed exclusively in testis (Parisi et al., 2004). The scale bar represents the evolutionary
change per residue. Proteins are designated by their published name or GenBank accession number, and abbreviated species names are as follows
(from top to bottom): H. sapiens, M. musculus, X. laevis, D. rerio; A. melifera, A. gambiae, D. melanogaster, D. pseudoobscura, D. melanogaster,
C. elegans; D. discoideum, O. sativa, A. thaliana; S. cerevisiae, C. albicans, N. crassa, and S. pombe.
(B) ClustalW alignment of human Parafibromin, its zebrafish homolog, Drosophila Hyx, the C. elegans homolog, and yeast Cdc73p. Arrows indicate
predicted bipartite and classic nuclear localization signals (NLS). Red residues indicate positions of nonsense mutations affecting the Hyx sequence
in hyx2 and hyx1, respectively.against either lgs or hyx (Figure 3D). Importantly, the tran-
scription of the four Wg independent genes dRheb, TOR,
brinker (brk), and dInr showed no significant transcrip-
tional change in response to RNAi against either GFP,
Axin, lgs, hyx, or combinations thereof (Figure 3E). Since
hyx expression was only severely reduced but not abol-
ished in our in vivo and in vitro experiments, we cannot
rule out that pathways other than those governed by Wg
also depend on Hyx function but are more resilient to re-
ductions in its activity. In any case, our in vivo and tissue
culture results clearly indicate that hyx encodes an impor-
tant signaling component of the Wg pathway.
hyx Encodes the Drosophila Homolog
of Human Parafibromin
Interestingly, we found that eukaryotic genomes usually
contain a single potential hyx homolog (Figure 4A). The
presumptive Hyx protein sequence, however, did not re-
veal any functionally known domains with high confi-
dence. Based on similarity to the predicted metazoan pro-
teins, we subsequently identified three potential nuclear
localization signals (Figure 4B). These observations sug-
gest that Hyx represents a highly conserved and possibly
nuclear protein of ancient eukaryotic origin.332 Cell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc.The best characterized Hyx homolog is Cdc73p (Fig-
ures 4A and 4B), a nuclear factor of the Saccharomyces
cerevisiae Polymerase-Associated Factor 1 (PAF1) com-
plex. The PAF1 complex, comprising the factors Paf1p,
Cdc73p, Rtf1p, Ctr9p, and Leo1p, binds to RNAPII via
Cdc73p and Rtf1p and coordinates histone modifications
associated with transcription (reviewed by Sims et al.,
2004). Significant sequence similarity between Hyx and
Cdc73p is limited to the C-terminal part, starting approx-
imately from amino acid 359 in Hyx (Figure 4B). Interest-
ingly, Hyx shares with its metazoan homologs additional
sequence similarities in the N-terminal domain, which
are not present in yeast and plants, suggesting that these
proteins have acquired metazoan-specific functions (see
below).
The human homolog of Hyx has recently been discov-
ered to be the product of the HRPT2 tumor suppressor
gene involved in Hyperparathyroidism-Jaw Tumor syn-
drome (HPT-JT) (Carpten et al., 2002). Based on some of
this syndrome’s characteristic features—parathyroid tu-
mors and ossifying jaw fibromas—this product is referred
to as Parafibromin (Carpten et al., 2002). While the role of
Parafibromin in parathyroid glands and other tissues is un-
known at present, there is a tight correlation between
mutations in HRPT2 and familial, as well as sporadic,
cases of this disease (reviewed by Wang et al., 2005).
Based on these findings and our previous experimental
results, we hypothesized that Hyx—and by extension Par-
afibromin—represent nuclear factors of a metazoan PAF1
complex which mediate Wnt/Wg target gene activation
upon recruitment by the nuclear b-catenin/Arm complex.
In the subsequent experiments, we set out to verify and
refine this model.
Parafibromin Can Functionally Substitute for Hyx
To address the functional relationship between Hyx and
its human homolog, we generated a UAS-HRPT2 trans-
gene containing the entire Parafibromin protein coding re-
gion. As shown in Figures 5A–5C, expression of this trans-
gene fully reverted the Lgs17E-mediated wing notching
phenotype. Thus Parafibromin, like Hyx, has the capacity
to enhance the output of a compromised Wg pathway
upon overexpression.
We next established transgenic lines with a construct
encoding N-terminally HA-tagged Parafibromin driven by
the weak and ubiquitous tubulin-1a promoter (tub1a-
HA-HRPT2). All transgene insertions analyzed fully res-
cued all mutant hyx allele combinations to adulthood
without obvious phenotypic defects (Figure 5D). HA-Par-
afibromin was exclusively found in the nuclei of the trans-
gene-expressing cells, independent of their Wg pathway
activity (Figures 5E–5J) and consistent with a nuclear
function of Parafibromin/Hyx (Hahn and Marsh, 2005;
Rozenblatt-Rosen et al., 2005). An analogous construct
encoding yeast Cdc73p (tub1a-HA-cdc73), however, did
not show any significant rescue activity (data not shown).
Hence Parafibromin, but not Cdc73p, can serve as a func-
tional homolog of Hyx.
Together, these findings support our notion that Hyx is
a nuclear component involved in Wg target gene activa-
tion and raise the intriguing possibility that Parafibromin
and the Cdc73-related proteins in other metazoans have
a similar function.
Wnt Signaling in HEK 293T Cells Is Sensitive
To Parafibromin Levels
We next wanted to know if increased Parafibromin levels
positively influence Wnt signaling in human cells. HEK
293T cells were transfected with varying amounts of
a CMV-promoter driven HA-HRPT2 construct. Wnt path-
way activity was monitored with the TOPFLASH assay
(Korinek et al., 1997) upon induction by Lithium Chloride
(LiCl), an inhibitor of GSK-3b (Jho et al., 2002). Overex-
pression of Parafibromin caused a 2- to 3-fold increase
in TOPFLASH activity (Figure 5K), suggesting that Parafi-
bromin positively synergizes with components of the hu-
man Wnt signaling pathway to enhance the TCF/LEF-
dependent transcriptional output.
To decrease HRPT2 levels, we used two independent
small interfering RNAs (siRNAs) against HRPT2. Both
siRNAs knocked HRPT2 mRNA levels down to approxi-
mately 20% within 48 hr after transfection into HEK 293Tcells without any obvious deleterious effects on cell viabil-
ity or control-gene expression (data not shown). However,
comparable to the effect of an siRNA against hPYGO2,
knockdown of HRPT2 reduced the TOPFLASH readout
(Figure 5L). Since neither of the two HRPT2 siRNAs
matches the hyx mRNA sequence, we could introduce
Hyx to this system, essentially replacing Parafibromin
with its Drosophila homolog. When cotransfected with ei-
ther of the HRPT2 siRNA, our HA-hyx construct was able
to restore the TOPFLASH readout (Figure 5L and data not
shown). Interestingly, forms of Hyx that lack the N or the
C terminus as well as full-length yeast Cdc73p failed to
significantly reverse the RNAi effect (Figure 5M). Together,
these results indicate that Parafibromin is required for Wnt
signaling in human cells and that full-length Hyx can sub-
stitute for Parafibromin in this function. These findings
further support the notion that Parafibromin and Hyx are
bona fide orthologs and that metazoan Cdc73-related
proteins share a conserved role in nuclear Wnt signaling.
Existence of a Stable Parafibromin/b-catenin
Complex
The sequence homology to Cdc73p together with the re-
sults obtained so far suggest that Parafibromin/Hyx and,
by extension, the PAF1 complex promote Wnt/Wg target
gene expression. To test if there is a physical link between
Parafibromin and the nuclear b-catenin complex, we incu-
bated GST-DN-b-catenin or GST coupled to glutathione
sepharose beads with lysates of HEK 293T cells express-
ing HA-Parafibromin. GST-DN-b-catenin beads, but not
GST beads, efficiently retained HA-Parafibromin (Fig-
ure 6A); we could also precipitate a complex with HA-
Parafibromin using GST-hTCF41-130, a minimal hTCF4
fragment containing the b-catenin interaction domain (Fig-
ure 6B). Importantly, using an anti-Parafibromin antibody,
endogenous b-catenin could be coimmunoprecipitated
along with endogenous Parafibromin from HEK 293T
and HeLa cells as well as mouse embryonic fibroblasts
(Figures 6C and 6E and data not shown). Similarly, anti-
HA pull-downs from S2 cells transiently expressing HA-
Hyx coprecipitated endogenous Arm (data not shown).
Endogenous b-catenin could also be coprecipitated by
another component of the PAF1 complex, hLeo1 (Figures
6D and 6E), suggesting that the PAF1 complex as a whole
can stably interact with b-catenin in vivo.
Parafibromin/Hyx Directly Binds b-catenin/Arm
via a Confined Domain in Its Metazoan-Specific
N Terminus
The interaction between Parafibromin and b-catenin de-
scribed above could be either direct or indirect. Using
the yeast-2-hybrid system, we detected a specific interac-
tion between Parafibromin and b-catenin (Figure 6F), sug-
gesting direct protein–protein binding. More definite sup-
port for this was obtained from in vitro experiments in
which GST-Parafibromin and GST-Hyx efficiently pulled
down in vitro translated full-length b-catenin and N-termi-
nally truncated Arm, respectively (Figure 6G and data notCell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc. 333
Figure 5. Parafibromin Is the Functional Homolog of Hyx and Functions as a Nuclear Wnt Signaling Component
(A–C) Overexpression of Parafibromin influences salE>lgs17E. In contrast to control UAS-GFPNLS (B), expression of a UAS-HRPT2 transgene (C) re-
verts the salE>lgs17E phenotype.
(D) Constitutive expression (by means of a tubulin-1a promoter) of an HA-tagged HRPT2 can fully rescue the loss of hyx function.
(E–J) HA-Parafibromin (green) localises, like Lgs protein (blue), in the cell nuclei of the wing imaginal disc (E–G) and eye disc (H–J).
(K) Overexpression of either Parafibromin or Hyx enhances Wnt signaling in HEK 293T cells which have been induced by LiCl treatment (25 mM final
concentration for 24 hr) as measured by the TOPFLASH assay.
(L and M) Knocking down HRPT2 with two independent siRNAs reduces Wnt signaling to an extent comparable to targeting hPYGO2. Cotransfection
of HA-hyx can restore Wnt signaling. However, the isolated Hyx N terminus (hyxN, 1-348) and C terminus (hyxC, 349-538) as well as yeast Cdc73p
cannot substantially rescue the effect of HRPT2 siRNA (M). The Hyx C-terminal fragment additionally contains a SV40 largeT antigen NLS to ensure
proper nuclear translocation (Yart et al., 2005). In (K–M), the relative Luciferase activity is normalized to that obtained with expression ofCMV-EGFP or
using siRNA against GFP, respectively.shown). In an analogous complementary set of pull-
downs, GST-DN-b-catenin and GST-DN-Arm interacted
with in vitro translated full-length Parafibromin and Hyx
(Figure 6H and data not shown). Taken together, the inter-
action studies strongly suggest that Parafibromin/Hyx and
b-catenin/Arm coexist in a complex by virtue of a direct
protein–protein interaction.
To identify the region of b-catenin necessary for Parafi-
bromin binding, we performed a series of GST pull-down
assays with different in vitro translated b-catenin frag-334 Cell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc.ments. The results indicate that repeat 12 together with
the C-terminal domain (CTD) harbors a Parafibromin bind-
ing site (Figure 6G). We also found that Hyx interacts with
the corresponding part of Arm in a similar set of experi-
ments (data not shown), indicating that the interaction re-
gion is evolutionarily conserved. Our results also allow us
to conclude that the C-terminally truncated protein prod-
ucts of several mutant arm alleles, for example, Arm043A01
(lacking Arm repeats 10 to 12 and the CTD) or ArmXM19
(which lacks the entire CTD), no longer interact with Hyx.
Figure 6. b-catenin and the PAF1 Complex Interact In Vivo
(A and B) HA-Parafibromin from HEK 293T cells precipitates with GST-DN-b-catenin but not with GST alone (A).
(B) GST-hTCF41-130 is also able to precipitate HA-Parafibromin from lysates coexpressing constitutively active b-cateninS33Y.
(C) Endogenous b-catenin coimmunoprecipitates with Parafibromin. Endogenous Parafibromin was immunoprecipitated, using the anti-Parafibromin
antibody BL649, from the lysates of HEK 293T cells induced with LiCl. An unrelated isotype-matched antibody was used as a control.
(D) b-catenin from LiCl-treated HEK 293T cells was coimmunoprecipitated along with another PAF1 complex component, hLeo1, by an anti-hLeo1
antibody (BL677). This interaction is presumably indirect, as GST-pulldowns failed to detect an interaction between Arm and dLeo1 (data not shown).
(E) Same interactions as depicted in (C) and (D) but using HeLa rather than HEK 293T cells.
(F) Parafibromin binds to b-catenin in a yeast-2-hybrid assay. Using Parafibromin as bait an interaction with human b-catenin is detected, but not with
the independent Sp1-related transcription factor Huckebein (Hkb) prey.
(G) Parafibromin binds to a region spanning repeat 12 and the C-terminal domain (CTD) of b-catenin. Constructs for the indicated truncations were
in vitro translated and tested for binding to GST-Parafibromin and GST. The minimal interaction domain is indicated as red bar. Note the abolishment
of the interaction upon separation of the Arm repeat region from the CTD. The interaction is also weakened, yet not abolished, by removing the less
conserved distal CTD part (723-781).
(H) Full-length and C-terminally, but not N-terminally, truncated Parafibromin binds DN-b-catenin. In vitro translated Parafibromin fragments were
tested for their ability to bind GST-fused DN-b-catenin and the GST control.We next mapped the b-catenin/Arm binding domain of
Parafibromin/Hyx. A GST-fusion comprising the N termi-
nus (amino acids 1–343) of Parafibromin interacted with
b-catenin in vitro, while the C-terminal half of Parafibromin
(amino acids 344–538), harboring the core Cdc73 homol-
ogy region, failed to do so (Figure 7A). Further truncations
allowed us to define a stretch of amino acids (200–250)
essential for b-catenin binding (Figure 7A). This stretch
corresponds to an evolutionarily conserved block in Paraf-
ibromin/Hyx proteins centered on amino acids 218–263,
which itself turned out to be sufficient for potent b-catenin
binding (Figure 7A). We therefore propose that amino
acids 218–263 of Parafibromin constitute a discrete
b-catenin interaction domain (CID) (Figures 4 and 7B). Inaddition to the CID, our genetic analysis in vivo and the
ClustalW alignments suggest that the Parafibromin/Hyx
N terminus might contain further ‘‘activator binding’’ do-
mains, potentially linking the PAF1 complex to other tran-
scription-dependent signaling outputs.
Parafibromin Function in Wnt Signaling Depends
on BCL9/Lgs and Pygo
Originally, we found that hyx overexpression could coun-
teract the dominant-negative effect of Lgs17E, suggesting
a functional crosstalk between Hyx and Lgs/Pygo. We
thus asked whether the Parafibromin/Hyx-mediated out-
put of b-catenin activity is dependent on BCL9/Lgs and
Pygo. We made use of the Parafibromin activity assayCell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc. 335
Figure 7. The CID in the Parafibromin/Hyx N Terminus Directly Binds the C-terminal Region of b-catenin/Arm to Mediate Wnt
Signaling in a Pygo-Dependent Manner
(A) The Parafibromin N terminus and, in particular, the b-catenin interaction domain (CID) region are sufficient for b-catenin binding. Numbers indicate
amino acid residues of Parafibromin used to generate GST fusion proteins. GST alone as well as the unrelated GST-GFP and GST-dTAB2 (Geuking
et al., 2005) fusion proteins served as negative controls and GST-hTCF1-130 as positive control.
(B) ClustalW alignment of the highly conserved CID region from human, X. laevis, D. rerio, A. melifera, D. melanogaster, and A. gambiae Parafibromin/
Hyx proteins.
(C) siRNA-mediated knockdown of hPYGO2 abrogates LiCl-induced Wnt signaling and enhancement of signaling seen by cotransfecting HA-HRPT2
when compared to the GFP siRNA control.
(D) Overexpression of Parafibromin enhances the signaling of a UAS-Luciferase reporter construct when coexpressed with a Gal4 DNA binding
domain (G4DBD)-DN-b-catenin fusion protein but not when coexpressed with a fusion protein comprising a mutant form of b-catenin that is unable
to recruit BCL9 (G4DBD-DN b-cateninD164A).
(E) hBCL9, hPygo2, and b-catenin, but not HA-hPygo2DPHD, can be coimmunoprecipitated with Parafibromin. Endogenous Parafibromin was immu-
noprecipitated from lysates of HEK 293T cells stimulated with LiCl. An unrelated isotype-matched antibody was used as a control. The multiple
HA-BCL9 bands may represent phosphorylated or otherwise modified forms of BCL9.
(F) Proposed mode of action for the nuclear Wnt/Wg signaling core complex. BCL9/Lgs recruits Pygo to TCF/LEF bound b-catenin at its N-terminal
Arm repeats, exposing the Pygo NHD. Parafibromin/Hyx recruits the PAF1 complex and binds directly via its CID to the b-catenin/Arm C-terminal part,
potentially after CBP/p300 and Brg-1/Brm have remodeled surrounding chromatin to enable RNAPII transactivation. Following mRNA transcription
initiation, the PAF1 complex could be transferred together with Parafibromin/Hyx to RNAPII in order to control histone modifications associated with
transcriptional elongation.described above, in which an increase in Parafibromin
levels enhances the transcriptional activity of the TOPFLASH
reporter upon pathway stimulation (see Figure 5K). This
enhancement of pathway activity was greatly reduced336 Cell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc.when hPYGO-2 was targeted by RNAi, indicating that
pathway stimulation by increased levels of Parafibromin
depends on Pygo (Figure 7C). To corroborate this con-
clusion and extend it to BCL9/Lgs, we used a mutant
form of b-catenin that can no longer recruit BCL9/Lgs due
to a single amino acid exchange in its BCL9/Lgs binding
site (D164A) (Hoffmans and Basler, 2004). While the activ-
ity of wild-type b-catenin tethered to DNA by a Gal4 DNA
binding domain (G4DBD-b-cateninwt) shows an enhanced
UAS-Luciferase transcription when Parafibromin is over-
expressed, the mutant form (G4DBD-b-cateninD164A) is
no longer responsive to increased levels of Parafibromin
(Figure 7D). This apparent epistatic relationship between
BCL9-Pygo and Parafibromin could be interpreted to indi-
cate that Parafibromin/Hyx acts downstream of, or in
parallel to, BCL9/Lgs-Pygo. Given that both factors are re-
cruited to b-catenin, a parallel concomitant action is more
likely.
In agreement with this notion, we found biochemical ev-
idence that the Parafibromin/b-catenin complex also con-
tains BCL9 and Pygo. Full-length HA-BCL9 or HA-hPygo2
as well as a C-terminally truncated version of hPygo2 lack-
ing the BCL9-interacting PHD domain (HA-hPygo2DPHD)
were expressed in HEK 293T cells and immunoprecipated
with an anti-Parafibromin antibody. Western blot analysis
revealed that Parafibromin and b-catenin coprecipitated
with BCL9 and full-length hPygo2 but not with hPygo2DPHD
(Figure 7E). Together, our results indicate that the scaf-
fold protein b-catenin assembles a nuclear Wnt signaling
complex comprising BCL9/Lgs-Pygo as well as Parafibro-
min. They further suggest that the transcriptional output of
b-catenin depends on the concomitant activities of Pygo
and the PAF1 complex, providing an explanation for our
original finding that overexpression of Hyx could com-
pensate for the experimental reduction of Lgs function
in vivo.
DISCUSSION
Wnt signaling proteins govern many important cellular
events during development, tissue homeostasis, and tu-
morigenesis. In most cases, the effects of these signals
are brought about by transcriptional changes of target
genes. It is thought that Wnt targets are activated by
b-catenin-mediated recruitment of auxiliary factors to TCF/
LEF DNA binding proteins. Despite the identification of
both dedicated and more general factors influencing the
transcriptional output of b-catenin activity, little is known
about how these proteins act together to control Wnt tar-
get gene expression. Here we extend the current under-
standing of Wnt/Wg signaling by the genetic identification
and molecular characterization of Hyrax (Hyx) and its hu-
man ortholog Parafibromin, a novel transcriptional media-
tor of b-catenin/Arm. Parafibromin/Hyx is homologous to
Cdc73p, a component of the Saccharomyces cerevisiae
PAF1 complex, which is an evolutionarily conserved
RNA Polymerase II interacting complex involved in regu-
lating transcriptional initiation and elongation. The results
presented here suggest a model for Wnt/Wg target gene
control in which the C-terminal region of b-catenin recruits
Parafibromin/Hyx, thereby engaging the PAF1 complex
for the transcriptional upregulation of target genes.Hyx As a Novel Wg Pathway Component
Three lines of evidence argue for the notion that Hyx rep-
resents a component of the Wg pathway. (1) Our initial ob-
servation that increased expression of hyx can overcome
the dominant-negative effect of overexpressed lgs17E pro-
vides a first indication that Hyx positively influences Wg
signaling outputs in vivo. lgs17E encodes an altered form
of Lgs which contains a mutation in its Arm-interacting do-
main that severely decreases binding of Lgs to Arm and
consequently the recruitment of Pygo to Arm. When pro-
vided in excess, Lgs17E protein likely impairs the function
of nuclear Arm by outcompeting endogenous Lgs and
thus disturbs the sensitive balance and/or sequence of
factors normally recruited at Wg-responsive enhancers.
Elevating the levels of a positively acting nuclear factor in-
volved in Wg signaling, in this case Hyx, could readily ex-
plain the reversion of the Lgs17E phenotype in our genetic
assays. (2) Our subsequent observation that genetic re-
duction of hyx function in imaginal discs as well as the
RNAi-mediated knock-down of hyx expression in S2 cells
caused a severe decrease in Wg pathway activity is a
strong argument for a requirement of Hyx in Wg signaling.
(3) Ultimate confirmation of the above genetic claims was
our discovery of Hyx as a direct binding partner of Arm.
Together these observations provide a solid basis for
a model in which Hyx plays a key role in mediating the
transcriptional output of Arm in response to Wg pathway
activation. In contrast to the Arm partners Lgs and Pygo,
Hyx is most likely not a component dedicated solely to
the Wg pathway. The phenotypes associated with hyx
loss-of-function mutations indicate that Hyx is involved
in other developmental processes, possibly in the tran-
scriptional output of some other signal transduction path-
way(s).
A Conserved PAF1-Like Complex Involved
in Wnt Signaling
The high degree of homology between Hyx and its single
human ortholog suggested that Parafibromin serves the
same function in Wnt signaling as Hyx in Wg signaling. In-
deed, with the exception of genetic evidence for an in vivo
requirement, equivalent lines of reasoning as those out-
lined above for Hyx argue for an important role of Parafi-
bromin in human b-catenin signaling. What could this
role be? It has recently been shown that Parafibromin/
Hyx represents the Cdc73 subunit of a metazoan PAF1
complex (Rozenblatt-Rosen et al., 2005; Yart et al., 2005;
Adelman et al., 2006). The yeast PAF1 complex has orig-
inally been found associated with initiating and elongating
forms of RNAPII (reviewed by Sims et al., 2004). Moreover,
the PAF1 complex interacts genetically and physically
with the histone H2B ubiquitination complex, the Set1
methylase-containing COMPASS complex, and Set2,
thus conferring control over a number of distinct histone
modifications on RNAPII (reviewed by Hampsey and
Reinberg, 2003; Krogan et al., 2003; Wood et al., 2003).
Together, these findings suggest important conserved
functions of the PAF1 complex in coordinating histoneCell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc. 337
modifications ‘‘downstream’’ of chromatin preparation on
target promoters to ensure proper initiation, elongation,
and memory of transcription (reviewed by Sims et al.,
2004).
To date, Cdc73p has not been reported to interact di-
rectly or indirectly with a sequence-specific DNA binding
transcription factor, and it is not clear how the PAF1 com-
plex is recruited to its target genes. However, the meta-
zoan homologs Parafibromin and Hyx share an extended
N-terminal region, not present in Cdc73p, which we have
found to physically interact with the core Wnt/Wg compo-
nent b-catenin/Arm. It is thus tempting to speculate that
during metazoan evolution, Cdc73 homology proteins
evolved in their N-terminal sequences interaction domains
for certain signal transduction pathways, such as the Wnt/
Wg pathway, while conserving C-terminal sequences for
PAF1 complex and/or RNAPII association.
Pygo As a Potential Coordination Module for
Transcriptional Activators at the C Terminus
of b-catenin/Arm
b-catenin/Arm has two ‘‘branches’’ of transcriptional out-
put, an N-terminal and a C-terminal branch, which can be
separated experimentally (Sta¨deli and Basler, 2005). The
N-terminal activity maps to Arm repeat 1 and can be attrib-
uted to the recruitment of Lgs and Pygo (Hoffmans et al.,
2005; Sta¨deli and Basler, 2005). Our results here suggest
that Parafibromin/Hyx mediates an important aspect of
the C-terminal output of b-catenin/Arm. The significance
of any transcriptional activity mapping to C-terminal se-
quences of b-catenin/Arm is seemingly undermined by
the finding that C-terminally truncated forms of Arm
(such as the product of the allele armXM19) are able to drive
Wg target gene expression under certain experimental
conditions (Cox et al., 1999; Tolwinski and Wieschaus,
2004). However, the armXM19 allele only exhibits robust
signaling activity when its product is ‘‘forced’’ into the nu-
cleus by overexpression of a membrane-tethered form of
Arm and most likely uses the N-terminal Lgs/Pygo-depen-
dent branch for this activity. Under physiological condi-
tions, ArmXM19 is severely impaired for Wg signaling (Pei-
fer et al., 1994; Cox et al., 1999). ArmH8.6, which only lacks
a distal portion of the CTD, retains residual transactivation
potential at 18ºC (Cox et al., 1999). This apparent correla-
tion between signaling activity and the extent of C-termi-
nal integrity of Arm might reflect the capacity of Arm to
recruit Hyx, a view consistent with our protein–protein
interaction results.
Recent advances in the understanding of how transcrip-
tional activators modulate gene transcription suggest a
sequential recruitment of histone acetylases (such as
CBP/p300) and chromatin-remodeling complexes (like
SWI/SNF) to target genes before RNAPII is contacted to
initiate transcription on the prepared chromatin (reviewed
by Narlikar et al., 2002; Roeder, 2005). The b-catenin re-
gion encompassing Arm repeat 11 to the C terminus has
previously been implicated in being necessary for chro-
matin remodeling using in vitro assays (Tutter et al., 2001).338 Cell 125, 327–341, April 21, 2006 ª2006 Elsevier Inc.Parafibromin/Hyx interacts with a region of b-catenin/Arm
(repeat 12-C) (Figure 6G) that overlaps with the CBP/p300
binding site (repeat 10/11-C) and the Brg-1/Brm binding
region (repeat 7-12) (Hecht et al., 2000; Takemaru and
Moon, 2000; Barker et al., 2001). This raises the intriguing
possibility of a concerted or sequential recruitment of
chromatin remodeling factors during the control of Wnt/
Wg-responsive genes to the C-terminal portion of b-cate-
nin/Arm, as is being reported for an increasing number of
transcription factors (reviewed by Narlikar et al., 2002;
Roeder, 2005). In such a scenario, CBP/p300 and Brg-1/
Brm would, in sequential or arbitrary order, mediate chro-
matin remodeling steps at b-catenin/Arm-dependent
target genes before the Parafibromin/Hyx-mediated re-
cruitment of a PAF1-like complex orchestrates later trans-
activation steps involving the preparation of RNAPII with
histone methylase complexes. In a final step, the PAF1
complex, including Parafibromin/Hyx, may be transferred
from b-catenin/Arm to RNAPII to travel with it through the
actively transcribed gene.
What role does the Wnt/Wg pathway component Pygo
play in such a model? We found in several readouts that
the Parafibromin/Hyx-enhanced transactivation activity
of b-catenin is dependent on Pygo (Figures 1A–1F, 7C,
and 7D). We interpret the Pygo-Parafibromin/Hyx depen-
dence as an indication for a more general cross talk be-
tween Pygo and proteins interacting with the C-terminal
region of b-catenin/Arm (Figure 7F). Thus, Pygo could
act as a flexible recruitment module to facilitate the ex-
change or stabilization of transactivating complexes that
sequentially bind to the b-catenin C terminus. We there-
fore propose that Wnt/Wg target gene activation might
be a concerted, Pygo-guided process, which dynamically
coordinates the sequential action of transcriptional modu-
lators at the central scaffold protein b-catenin/Arm.
Specificity
The yeast PAF1 complex shows cotranscriptional associ-
ation with a wide range of genes and has therefore been
considered a general transcription cofactor complex.
However, deletion of individual components of this com-
plex does not have a global effect on mRNA transcription
but instead has a more selective impact on the transcrip-
tion of only a subset of genes (Shi et al., 1997; Porter et al.,
2002). Currently, aside from our findings of an involvement
in Wnt signaling, little is known about the target gene
spectrum of metazoan PAF1-like complexes. Recently
published data indicate that, as in yeast, the Drosophila
PAF1-like complex is broadly associated with active
genes but, functionally, Cdc73/Hyx seems only necessary
for a subset of PAF1 complex targets (Adelman et al.,
2006). This would be consistent with a view that Parafibro-
min and Hyx provide an adaptor function only to certain
transcription factors, such as, for example, b-catenin
and Arm. Indeed, our in vivo and in vitro assays indicate
that in contrast to a cohort of other genes, whose expres-
sion is constitutive or controlled by other pathways, Wg
targets are remarkably sensitive to reduction of Hyx levels.
However, since our assays severely reduced but never
abolished hyx expression, we can currently not evaluate
the extent to which Hyx activity is also required for the
transcription of targets of other pathways, which poten-
tially are more resilient to reductions in Hyx levels.
Hyperparathyroidism, Parafibromin,
and Wnt Signaling
Originally, HRPT2 has been cloned as the tumor suppres-
sor gene responsible for HPT-JT in both familial and spo-
radic cases (reviewed by Wang et al., 2005). Little is known
about the seemingly complex molecular pathology of
parathyroid tumors and HPT-JT in particular (reviewed
by Hendy, 2000). Constitutive Wnt signaling is causally in-
volved in many different tumor types. However, our find-
ings clearly indicate a positive role for Parafibromin in
the Wnt pathway; loss-of-heterozygosity of the HRPT2
tumor suppressor gene is thus expected to compromise
rather than enhance pathway output. One way to recon-
cile this apparent discrepancy between a tumor suppres-
sor function of HRPT2 and a positive sign of action of its
product in Wnt signaling is to postulate that the transcrip-
tional target(s) of Parafibromin relevant for HPT-JT en-
codes a negative growth regulator. It will be interesting
to find out whether loss-of-function mutations in other
positive Wnt pathway components might also cause hy-
perparathyroidism. It is also possible that the expression
of the critical Parafibromin target(s) depends on another
pathway that adopted the PAF1 complex for efficient tar-
get gene control. Clarification of these important issues
will have to await the identification and analysis of the
presumptive Parafibromin target(s) whose product(s) nor-
mally prevent parathyroid cancer.
EXPERIMENTAL PROCEDURES
Fly Stocks
For specificity assays, the following tester lines were used. Dpp: s168-
Gal4, UAS-brk. Insulin pathway: GMR-Gal4, UAS-Inr. EGFR: GMR-
Gal4, Tsev11.5 and GMR-Gal4, UAS-egfrDN. TNF/Eiger: GMR-Gal4,
UAS-egr. Other stocks used were Act5C-Gal4, dpp-lacZ, ptc-lacZ,
omb-lacZ. Clonal analysis was done with yw hsp70-flp; FRT82 ubi-
GFP/TM6b and yw hs-flp f-; FRT82B2 M(3)95A ubi-GFP/TM6b.
Immunohistochemistry
Antibodies used were mouse monoclonal anti-b-Gal (1:2000, Prom-
ega), mouse monoclonal anti-Dll (1:2000), mouse monoclonal anti-
Cut (1:20), rabbit polyclonal anti-Lgs (1:500), and mouse HA11
(1:1000, BAbCO). Goat secondary antibodies were coupled to Alexa488
and Alexa594 (1:400, Molecular Probes).
Vectors and Constructs
hyx constructs were PCR generated using the EST LD47989. HRPT2
constructs were based on the full-length EST V-1314 (Genecopoeia).
Expression and IVT constructs were cloned into pcDNA3 (Invitrogen)
and GST fusion constructs into pGEX-KG (Guan and Dixon, 1991). De-
tailed descriptions of all constructs are available on request. The Gen-
Bank accession number for hyrax is DQ305403.
S2 Cell Culture and Quantitative Real-Time PCR
RNAi in S2 cells was performed as described by Worby et al. (2001).
Cells were incubated for 24 hr to allow for turnover of the target proteinbefore the Wg pathway was activated by coculture with Wg-producing
cells (van Leeuwen et al., 1994). Primer sequences used to generate
specific dsRNAs can be obtained on request.
Total RNA was extracted from S2 cells using the Nucleospin RNA II
kit (Macherey-Nagel). Quantitative PCR reactions were performed in
triplicates and monitored using the Applied Biosystems SYBR Green
kit and the ABI Prism 7900HT System (Applied Biosystems). All results
were simultaneously normalized to the Actin5C, tubulin-1a, and TBP
mRNA levels and calculated using the DDCt method (Applied Biosys-
tems user bulletin #2, updated version 04/2001).
Mammalian Cell Culture Experiments
For TOPFLASH assays, HEK 293T cells were seeded at a density of 2–
2.5  105 cells/ml in DMEM, 10% FCS, 1% P/S and transfected 24 hr
later with a total of 1.25 mg plasmid DNA per ml of medium by the Cal-
cium Phosphate transfection method (0.5 mg pTOPFLASH, 0.25 mg
CMV-RL, and 0.5 mg cargo or empty vector). In siRNA experiments,
3 mg siRNA per ml of medium was cotransfected. After 16–20 hr, the
medium was replaced. Cells were stimulated by addition of LiCl or
NaCl (control) at 25 mM final concentration 24 hr before harvesting.
Cells were harvested 48 hr or 72 hr (siRNA experiments) after transfec-
tion, and Luciferase activities were measured by the Promega Dual-
Luciferase reporter assay system. siRNAs (Qiagen) were:
HRPT2: 50-CACGAACAACTATCTTACAAA(dTdT)-30 (1) and 50-CAG
CGATCTACTCAAGTCAAA(dTdT)-30 (2); hPYGO2: 50-AACGATGACC
AGGATGCCATT(dTdT)-30.
Protein Interaction Studies
The yeast-2-hybrid system and pull-down experiments were done as
described in Kramps et al. (2002). For immunoprecipitation experi-
ments, HEK 293T cells were lysed in NP-40 lysis buffer (Rozenblatt-
Rosen et al., 2005). Antibodies used included mouse anti-FLAG (M2,
Sigma); mouse HA-11 (BAbCO); rabbit a-HA (ICL); rabbit anti-Parafi-
bromin and anti-hLeo1 (BL648, BL649, and BL677; Bethyl Labs) (Ro-
zenblatt-Rosen et al., 2005); and mouse anti-b-catenin (clone 14, BD
Biosciences).
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